Invivyd Inc. share price logo

Invivyd Inc.

NASDAQ: IVVD

Small Cap

$1.16

-0.31

(-21.09%)

as on

Invivyd Inc. Stock Performance

as on May 15, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.11
    $1.31
    downward going graph

    4.31%

    Downside

    12.93%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.48
    $3.07
    downward going graph

    58.36%

    Downside

    164.65%

    Upside

    downward going graph

Invivyd Inc. share price movements today

Previous Close
$1.47
Open
$1.31
Volume
11.4M
Day's Low - High
$1.11 - $1.31
52 Week Low - High
$0.48 - $3.07

Invivyd Inc. Historical Returns

1 Month Return
-32.16 %
3 Month Return
-25.64 %
1 Year Return
+ 64.77 %
3 Year Return
-24.18 %
5 Year Return
0 %

Invivyd Inc. Stock Fundamentals & Key Indicators

Check Invivyd Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$341.7M

EPS (TTM)

-0.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-54.8M

Revenue (TTM)

53.4M

Profit Margin

-98.25%

Return On Equity TTM

-33.97%

Invivyd Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Invivyd Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Invivyd Inc. image
Invivyd Inc.
BUY$341.7MNANA-98.25%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.9B116.25%73.0512.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$31.6BNA68.928.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$115.0B107.48%26.8935.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$75.5B37.99%17.5829.65%

Stock Returns calculator for Invivyd Inc. Stock including INR - Dollar returns

The Invivyd Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Invivyd Inc. investment value today

Current value as on today

₹1,85,815

Returns

₹85,815

(+85.81%)

Returns from Invivyd Inc. Stock

₹65,714 (+65.71%)

Dollar Impact

₹20,100 (+20.1%)

Analyst Recommendation on Invivyd Inc. Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Invivyd Inc.. Average target price of $10

Invivyd Inc. Share Price Target

Get share price movements and forecasts by analysts on Invivyd Inc..

What analysts predicted

88.4%UPSIDE

Target Price

$10

Current Price

$1.16

Analyzed by

10 Analysts

Target

$10.00

Invivyd Inc. target price $10, a slight upside of 88.4% compared to current price of $1.16. According to 10 analysts rating.

Indian Investors' Interest in Invivyd Inc. Stock

Search interest for Invivyd Inc. Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:26% versus previous 30 day period

Invivyd Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
3
-
2
9
13
11
11
13
17
Gross Profit
0
2
0
2
8
13
10
11
12
16
Operating Income
-43
-76
-46
-49
-62
-19
-16
-15
-11
-12
EBITDA
-37
-76
-45
-48
-61
-17
-16
-14
-10
-12
Interest Expense
-
3
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
1
0
0
0
0
Income Before Tax
-39
-73
-43
-47
-60
-18
-16
-14
-10
-11
Income Tax Expense
0
4
0
-
-
0
-
-
-
-
Net Income
-39
-73
-43
-47
-60
-18
-16
-14
-10
-11
Net Profit Margin
0.00%
-2435.65%
0.00%
-2086.88%
-653.11%
-133.45%
-144.10%
-124.38%
-79.75%
-64.33%

Invivyd Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
25
53
Gross Profit
0
0
-2
23
49
Operating Income
-226
-248
-212
-176
-55
EBITDA
-219
-225
-205
-173
-53
Interest Expense
14
43
-
-
-
Depreciation
0
0
1
3
2
Income Before Tax
-226
-241
-198
-169
-52
Income Tax Expense
7
-6
-
-
-
Net Income
-226
-241
-198
-169
-52
Net Profit Margin
0.00%
0.00%
0.00%
-669.42%
-98.25%

Invivyd Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-73
-43
-47
-60
-18
-16
-14
-10
-11
Operating Cash Flow
-59
-50
-41
-41
-37
-21
-13
-8
-15
Investing Cash Flow
77
0
-
0
0
0
0
-
-
Financing Cash Flow
0
39
0
0
0
0
0
58
157
Change in Cash
18
-11
-41
-41
-37
-21
-13
50
141

Invivyd Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-226
-241
-198
-169
-52
Operating Cash Flow
-184
-219
-173
-170
-58
Investing Cash Flow
-50
-230
280
0
0
Financing Cash Flow
662
0
1
39
215
Change in Cash
427
-450
108
-131
157

Mutual Funds that own Invivyd Inc. Stock

Check out the Mutual Funds with significant holdings in Invivyd Inc..

Funds
Holdings
Shares Held
Motilal Oswal S&P 500 Index Fund Direct Growth
Motilal Oswal S&P 500 Index Fund Direct Growth
0.02613%
4177

Global Institutional Holdings in Invivyd Inc.

Funds
Holdings
HHG PLC
11.51%
Eventide Asset Management, LLC
2.05%
Geode Capital Management, LLC
0.73%
State Street Corp
1.99%
Ikarian Capital, LLC
0.94%
See all

Invivyd Inc. News & Key Events

  • img

    Today's Timeline - 06 October

    Mon, 05:02 PM

    -

    Invivyd receives FDA clearance for VYD2311 trials, aiming for COVID-19 prevention with results expected by mid-2026.

Insights on Invivyd Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IVVD has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 31.8% return, outperforming this stock by 35.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, IVVD stock has moved down by -14.0%

About Invivyd Inc.

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.
OrganisationInvivyd Inc.
Headquarters209 Church Street, New Haven, CT, United States, 06510
IndustryBiotechnology
CEOMr. William E. Duke Jr., M.B.A.
E-voting on sharesClick here to vote

Key Management of Invivyd Inc.

Name

Title

Mr. William E. Duke Jr., M.B.A.

CFO, Principal Accounting Officer & Principal Executive Officer

Ms. Jill Andersen J.D.

Chief Legal Officer & Corporate Secretary

Dr. Robert D. Allen Ph.D.

Chief Scientific Officer

Ms. Kristie Coneys Kuhl J.D.

Chief Communications Officer

Ms. Katie Falzone CPA

Senior Vice President of Finance

Mr. Timothy Lee

Chief Commercial Officer

Ms. Julie Green M.B.A.

Chief Human Resources Officer

Ms. Rachael Gerlach Ph.D.

Senior Vice President of Regulatory Affairs

Dr. Michael J. Mina M.D., Ph.D.

Chief Medical Officer

FAQs

What is Invivyd Inc. share price today?

Invivyd Inc. share price today is $1.16 as on at the close of the market. Invivyd Inc. share today touched a day high of $1.31 and a low of $1.11.

What is the 52 week high and 52 week low for Invivyd Inc. share?

Invivyd Inc. share touched a 52 week high of $3.07 on and a 52 week low of $0.48 on . Invivyd Inc. stock price today i.e. is closed at $1.16,which is 62.21% down from its 52 week high and 140.17% up from its 52 week low.

What is Invivyd Inc.'s market capitalisation today?

Invivyd Inc. market capitalisation is $0.00T as on .

How to invest in Invivyd Inc. Stock (IVVD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Invivyd Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Invivyd Inc. Shares that will get you 1.2931 shares as per Invivyd Inc. share price of $1.16 per share as on May 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy Invivyd Inc. Stock (IVVD) from India?

Indian investors can start investing in Invivyd Inc. (IVVD) shares with as little as ₹95.753 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.53 in Invivyd Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Invivyd Inc. share’s latest price of $1.16 as on May 15, 2026 at 8:46 am IST, you will get 8.6207 shares of Invivyd Inc.. Learn more about fractional shares .